Auswahl der wissenschaftlichen Literatur zum Thema „Antitumoral properties“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Antitumoral properties" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Antitumoral properties"
Fabiani, Roberto. „Antitumoral Properties of Natural Products“. Molecules 25, Nr. 3 (03.02.2020): 650. http://dx.doi.org/10.3390/molecules25030650.
Der volle Inhalt der QuelleMcLachlan, J. A., C. D. Serkin, K. M. Morrey und O. Bakouche. „Antitumoral properties of aged human monocytes.“ Journal of Immunology 154, Nr. 2 (15.01.1995): 832–43. http://dx.doi.org/10.4049/jimmunol.154.2.832.
Der volle Inhalt der QuelleBraca, A. „Insight on antitumoral properties of plant diterpenes“. Planta Medica 81, S 01 (14.12.2016): S1—S381. http://dx.doi.org/10.1055/s-0036-1596105.
Der volle Inhalt der QuellePandiella-Alonso, Atanasio, Elena Díaz-Rodríguez und Eduardo Sanz. „Antitumoral Properties of the Nutritional Supplement Ocoxin Oral Solution: A Comprehensive Review“. Nutrients 12, Nr. 9 (31.08.2020): 2661. http://dx.doi.org/10.3390/nu12092661.
Der volle Inhalt der QuelleLungu, Claudiu N., Bogdan Ionel Bratanovici, Maria Mirabela Grigore, Vasilichia Antoci und Ionel I. Mangalagiu. „Hybrid Imidazole-Pyridine Derivatives: An Approach to Novel Anticancer DNA Intercalators“. Current Medicinal Chemistry 27, Nr. 1 (18.02.2020): 154–69. http://dx.doi.org/10.2174/0929867326666181220094229.
Der volle Inhalt der QuelleIacopetta, Domenico, Jessica Ceramella, Alessia Catalano, Carmela Saturnino, Maria Grazia Bonomo, Carlo Franchini und Maria Stefania Sinicropi. „Schiff Bases: Interesting Scaffolds with Promising Antitumoral Properties“. Applied Sciences 11, Nr. 4 (20.02.2021): 1877. http://dx.doi.org/10.3390/app11041877.
Der volle Inhalt der QuellePerez-Tomas, R., und M. Vinas. „New Insights on the Antitumoral Properties of Prodiginines“. Current Medicinal Chemistry 17, Nr. 21 (01.07.2010): 2222–31. http://dx.doi.org/10.2174/092986710791331103.
Der volle Inhalt der QuelleNava-Villalba, Mario, und Carmen Aceves. „6-Iodolactone, key mediator of antitumoral properties of iodine“. Prostaglandins & Other Lipid Mediators 112 (August 2014): 27–33. http://dx.doi.org/10.1016/j.prostaglandins.2014.07.001.
Der volle Inhalt der QuelleAdam, Gigi, Florina Daniela Cojocaru, Liliana Verestiuc, Oana Cioanca, Ingrid-Andrada Vasilache, Ana-Maria Adam, Cornelia Mircea et al. „Assessing the Antioxidant Properties, In Vitro Cytotoxicity and Antitumoral Effects of Polyphenol-Rich Perilla leaves Extracts“. Antioxidants 13, Nr. 1 (29.12.2023): 58. http://dx.doi.org/10.3390/antiox13010058.
Der volle Inhalt der QuelleEsteruelas, Gerard, Eliana B. Souto, Marta Espina, María Luisa García, Marta Świtalska, Joanna Wietrzyk, Anna Gliszczyńska und Elena Sánchez-López. „Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy“. Pharmaceutics 15, Nr. 1 (28.12.2022): 102. http://dx.doi.org/10.3390/pharmaceutics15010102.
Der volle Inhalt der QuelleDissertationen zum Thema "Antitumoral properties"
Panosa, Roqueta Clara. „Antitumoral properties of epidermal growth factor derivatives“. Doctoral thesis, Universitat de Girona, 2015. http://hdl.handle.net/10803/369050.
Der volle Inhalt der QuelleEls receptors i lligands de la família del factor de creixement epidèrmic (EGF)/ErbB són dianes molt importants en el desenvolupament de teràpies contra el càncer. No obstant, l’eficàcia terapèutica dels fàrmacs dirigits a atacar aquesta via i que són utilitzats actualment en clínica és limitada. Per aquest motiu la recerca de noves molècules que inactivin els receptors d’aquesta família mitjançant noves estratègies és avui dia una de les vies més explorades. En aquesta tesi s’ha desenvolupat un pèptid idèntic al factor de creixement epidèrmic EGF que li manca la seva part C-terminal (EGFt) com a nou inhibidor de EGFR. El disseny d’aquest pèptid truncat s’ha basat en la superposició tridimensional de l’estructura de l’EGF i de l’inhibidor de la carboxipeptidasa de patata (PCI), un bloquejador de la via de l’EGFR descrit prèviament pel nostre grup. El pèptid ha estat produït en E.coli i s’ha aconseguit obtenir un alt rendiment de la proteïna i amb la seva conformació estructural correcta. Hem observat que l’EGFt in vitro té una capacitat molt menor per induir dímers del receptor i també la seva fosforilació si la comparem amb l’activitat que té l’hEGF natiu. Per altra banda, l’EGFt promou la internalització del receptor i la seva translocació al nucli cel·lular tal i com ho fa l’hEGF, tot i que no estimula el creixement cel·lular. A més, l’EGFt competeix amb els lligands natius de la família i inhibeix la proliferació cel·lular. La manca d’activitat estimuladora del creixement cel·lular d’aquest pèptid quan s’uneix a l’EGFR ens va portar a provar la utilització de l’EGFt com a vehicle de toxines dirigit a cèl·lules tumorals que sobreexpresessin EGFR. Concretament, es va produir un radioconjugat de EGFt amb l’isòtop radioactiu emissor d’electrons Auger Indi-111. Les propietats d’aquest radioconjugat es van analitzar i es van comparar amb el radioconjugat produït amb hEGF natiu. En primer lloc es va determinar que 111In-DTPA-EGFt té una alta especificitat i afinitat per EGFR. No obstant, la captació cel·lular de 111In-DTPA-EGFt va resultar ser menor que la de 111In-DTPA-hEGF. Un cop internalitzat, 111In-DTPA-EGFt va mostrar una alta eficiència per acumular-se en el nucli de la cèl·lula, on la radioactivitat emesa per 111In danya l'ADN. 111In-DTPA-EGFt va mostrar ser citotòxic in vitro contra cèl·lules de càncer de mama, encara que la seva citotoxicitat va ser menor en comparació amb 111In-DTPA-hEGF. Els estudis in vivo van revelar una vida mitjana més llarga en sang per 111In-DTPA-EGFt que per 111In-DTPA-hEGF, una major captació en el ronyó i una menor acumulació en altres teixits normals. 111In-DTPA-EGFt es va detectar en els tumors de cèl·lules MDA-MB-468 on el radiocompost es va acumular preferentment en el nucli de la cèl·lula. Les dades recollides en aquest treball indiquen que l’EGFt pot tenir un gran potencial com a bloquejador en teràpia pel càncer i a més pot ser un bon lligand per utilitzar com a vehicle d’agents citotòxics dirigits al nucli de cèl·lules tumorals positives en EGFR.
Tonello, Andrea <1988>. „Synthesis and Engineering of PLGA-based Nanoparticles with antitumoral Properties“. Master's Degree Thesis, Università Ca' Foscari Venezia, 2014. http://hdl.handle.net/10579/5394.
Der volle Inhalt der QuelleZou, Yu. „Dendrimères et dendrons phosphorés : synthèse, propriétés et applications en nanomédecine“. Electronic Thesis or Diss., Université de Toulouse (2023-....), 2024. http://www.theses.fr/2024TLSES093.
Der volle Inhalt der QuelleThe objective of this thesis work was to prepare new phosphorous dendrimers or phosphorous dendrons, either neutral, cationic or anionic, with the aim of broadening the range of applications in the field of nanomedicine as molecules active by per se. or in combination with certain medications. In Chapter 1, the synthesis of a new polycationic phosphorus dendrimer comprising 5 pyrrolidinium groups on the surface and a protonated amine was successfully completed. This dendrimer associated with microRNA-30d makes it possible to obtain polyplexes which are transferred into cancer cells in an optimal N/P ratio of 10. These polyplexes are cytocompatible and transfer miR-30d to suppress glycolysis associated with SLC2A1. The inhibition of the migration and invasion of murine cancer cells in vitro and in vivo were thus demonstrated. This dendrimer can be considered as an important component for therapy based on the use of miR-30d. In Chapter 2, we develop a drug delivery system capable of penetrating BBB (blood brain barrier) to provide treatment for degenerative disorders. For this, the formation of a nanocomplex was developed consisting of a phosphorus dendrimer carrying hydroxyl groups on the surface, combined with fibronectin, which regulates proliferation and differentiation and cell motility. In a mouse model of Parkinson's disease, effective penetration at the level of the BBB of the phosphorous dendrimer assembly AK-123 and fibronectin was demonstrated, exerting an anti-inflammatory and antioxidant activity allowing to decrease effectively the symptoms observed and demonstrating the great potential for clinical treatment of Parkinson's disease but also hold great promise to be used to tackle other neurodegenerative disorders. In Chapter 3, the results obtained in the field of Parkinson's disease during the combined action of a generation 2 phosphorous dendrimer comprising 48 hydroxyl groups on the surface and fibronectin have encouraged us to diversify the nature and structure of these dendrimers in order to have first indications of their activity in general and to possibly approach a SAR (structure activity relationship) study. According to these, we prepared a whole set of new neutral phosphorus dendrimers of generations 1 and 2, characterized by internal structures different from those of the dendrimers used in the previous chapter, incorporating long chains on the surface and also comprising hydroxyl groups. These dendrimers have the advantage of having protonated amine groups allowing solubility in an aqueous medium. We were also able to prepare neutral and charged phosphorous dendrons. Preliminary results concerning their properties have been demonstrated. In Chapter 4, the aim of this study was focused on the synthesis of original anionic phosphorus dendrimers and the application of these dendrimers, and particularly of the dendrimer AK 137 which presents optimal anti-inflammatory activity and great efficiency for the delivery of proteins. We demonstrate that the AK-137@FN NCs association blocks the activation of certain signalling pathways (NF-kB and P13K/Akt), induces the polarization of macrophages towards M2 phenotypes, inhibits the secretion of pro-cytokines. (TNF-alpha, IL-1beta and IL6) and increases the antioxidant properties of FN in vitro. The therapeutic effects of the AK-137@FN combination have been demonstrated in ALI (acute lung injury) and AGA (acute gout arthritis) mouse models without observation of systemic toxicity
Salvador, Cátia Sofia Clemente. „Caracterização de cogumelos silvestres da espécie Amanita ponderosa: produção de metabolitos com atividade biológica“. Doctoral thesis, Universidade de Évora, 2014. http://hdl.handle.net/10174/13391.
Der volle Inhalt der QuelleBrink, Susanna. „Structure-activity relationships of titanocene complexes with antitumor properties“. Pretoria : [s.n.], 2003. http://upetd.up.ac.za/thesis/available/etd-09052005-101713/.
Der volle Inhalt der QuelleChen, Chujian 1966. „Antitumor properties of kefir : possible bioactive component(s) and mechanism(s)“. Thesis, McGill University, 2005. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=85139.
Der volle Inhalt der QuelleSun, Wai-yin Raymond, und 辛偉賢. „The antitumor and antiviral properties of gold (III) porphyrins and their related complexes“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B31245973.
Der volle Inhalt der QuelleZhang, Zhouen. „Tumor-targeting antitumor prodrugs and noninvasive molecular imaging probes : designs, syntheses and properties“. 京都大学 (Kyoto University), 2005. http://hdl.handle.net/2433/144557.
Der volle Inhalt der Quelle0048
新制・課程博士
博士(工学)
甲第11886号
工博第2579号
新制||工||1361(附属図書館)
23666
UT51-2005-N720
京都大学大学院工学研究科物質エネルギー化学専攻
(主査)教授 西本 清一, 教授 中條 善樹, 教授 木村 俊作
学位規則第4条第1項該当
BUSA', Rosalia. „Evaluation of antitumor and immunomodulatory properties of Indicaxanthin from Opuntia Ficus Indica (L. Mill) fruit“. Doctoral thesis, Università degli Studi di Palermo, 2020. http://hdl.handle.net/10447/395264.
Der volle Inhalt der QuelleMedvetz, Douglas Allen. „The Synthesis, Characterization, and Antitumor Properties of Ag(I), Cu(II), and Rh(III) Metal Complexes“. University of Akron / OhioLINK, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=akron1216840371.
Der volle Inhalt der QuelleBücher zum Thema "Antitumoral properties"
Fang, Evandro Fei, und Tzi Bun Ng, Hrsg. Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds. Dordrecht: Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-6214-5.
Der volle Inhalt der QuelleAntitumoral Properties of Natural Products. MDPI, 2020. http://dx.doi.org/10.3390/books978-3-03943-099-4.
Der volle Inhalt der QuelleAntitumoral Properties of Natural Products. MDPI, 2020. http://dx.doi.org/10.3390/books978-3-03943-115-1.
Der volle Inhalt der QuelleAntitumoral Properties of Natural Products. Mdpi AG, 2020.
Den vollen Inhalt der Quelle findenFang, Evandro Fei, und Tzi Bun Ng. Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds. Springer, 2015.
Den vollen Inhalt der Quelle findenFang, Evandro Fei, und Tzi Bun Ng. Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds. Springer, 2013.
Den vollen Inhalt der Quelle findenFang, Evandro Fei, und Tzi Bun Ng. Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds. Springer, 2013.
Den vollen Inhalt der Quelle findenFang, Evandro Fei, und Tzi Bun Ng. Antitumor Potential and Other Emerging Medicinal Properties of Natural Compounds. Springer London, Limited, 2013.
Den vollen Inhalt der Quelle findenBuchteile zum Thema "Antitumoral properties"
Varela, João, Catarina Vizetto-Duarte, Luísa Custódio, Luísa Barreira und Fernando Albericio. „Marine Peptides and Proteins with Cytotoxic and Antitumoral Properties“. In Marine Proteins and Peptides, 407–30. Chichester, UK: John Wiley & Sons, Ltd, 2013. http://dx.doi.org/10.1002/9781118375082.ch19.
Der volle Inhalt der QuelleSchumann, G. „Antiviral and Antitumor Effects of Liposome-Entrapped MTP-PE, a Lipophilic Muramylpeptide“. In Biological Properties of Peptidoglycan, herausgegeben von Peter H. Seidl und Karl H. Schleifer, 255–60. Berlin, Boston: De Gruyter, 1986. http://dx.doi.org/10.1515/9783110874297-032.
Der volle Inhalt der QuelleMalik, Fayaz, und Suresh Kumar. „Sesquiterpenes from Essential Oils with Promising Antitumor Properties“. In Bioactive Essential Oils and Cancer, 201–14. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-19144-7_9.
Der volle Inhalt der QuelleAttaway, John A. „Citrus Juice Flavonoids with Anticarcinogenic and Antitumor Properties“. In ACS Symposium Series, 240–48. Washington, DC: American Chemical Society, 1993. http://dx.doi.org/10.1021/bk-1994-0546.ch019.
Der volle Inhalt der QuelleKöpf-Maier, P. „Organometallic Titanocene and Ferricenium Complexes: Antitumor and Toxicologic Properties“. In Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, 601–11. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-1717-3_66.
Der volle Inhalt der QuelleSilbert, Jeremiah. „Lectins: Personal Comments of Nathan Sharon Taken from his Memoirs (Translation from Hebrew)“. In Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds, 3–11. Dordrecht: Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-6214-5_1.
Der volle Inhalt der QuelleVago, Riccardo, Rodolfo Ippoliti und Maria Serena Fabbrini. „Current Status and Biomedical Applications of Ribosome-Inactivating Proteins“. In Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds, 145–79. Dordrecht: Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-6214-5_10.
Der volle Inhalt der QuelleKennedy, Ann R. „The Health Benefits of the Bowman-Birk Inhibitor“. In Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds, 183–86. Dordrecht: Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-6214-5_11.
Der volle Inhalt der QuelleRolka, Krzysztof, Adam Lesner, Anna Łęgowska und Magdalena Wysocka. „Peptidic Inhibitors of Serine Proteinases of Plant Origin“. In Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds, 187–204. Dordrecht: Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-6214-5_12.
Der volle Inhalt der QuelleFurukawa, Kenei, Tadashi Uwagawa und Katsuhiko Yanaga. „Anti-Tumor Effect of Synthetic Serine Protease Inhibitor“. In Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds, 205–12. Dordrecht: Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-6214-5_13.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Antitumoral properties"
Bezerra, Natércia M. M., Gardênia C. G. Militão, Terezinha G. da Silva, Paulo H. Menezes und Roberta A. Oliveira. „Synthesis of Combretastatin A-4 Analogs with Antitumoral Properties“. In 14th Brazilian Meeting on Organic Synthesis. São Paulo: Editora Edgard Blücher, 2013. http://dx.doi.org/10.5151/chempro-14bmos-r0272-1.
Der volle Inhalt der QuelleLázaro, Rocío S. García, Humberto Lamdan, Norailys Lorenzo Perez, Lorena G. Caligiuri, Andrea L. Berengeno, Hugo H. Ortega, Daniel F. Alonso und Hernan G. Farina. „Abstract 3455: Preclinical evidences of antitumoral properties of a Yerba mate extract on breast and colon cancer models“. In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-3455.
Der volle Inhalt der QuelleYu, Henry, Hong-Ming Hu, Rongliang Lou, Wanping Geng, Sanlong Wang, William Redmond, Yoshinobu Koguchi, Baotian Qin, John Mao und Shaoshan Wang. „1171 CAN1012: a selective and potent TLR7 agonist with strong antitumoral properties mediated by localized innate immune activation“. In SITC 37th Annual Meeting (SITC 2022) Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-sitc2022.1171.
Der volle Inhalt der QuelleTikhonov, Sergey, Nataliya Tikhonova, N. V. Merzlyakova und A. S. Ozhgihina. „PEPTIDES AS A FUNCTIONAL INGREDIENT FOR PREVENTIVE PRODUCTS“. In I International Congress “The Latest Achievements of Medicine, Healthcare, and Health-Saving Technologies”. Kemerovo State University, 2023. http://dx.doi.org/10.21603/-i-ic-133.
Der volle Inhalt der QuellePatlay, A. A., M. E. Shmelev, V. E. Silant’ev und A. S. Belousov. „CREATION AND CHARACTERIZATION OF HYDROGELS BASED ON MODIFIED PECTINS WITH CUSTOMIZABLE PROPERTIES FOR THE THERAPY OF BRAIN TUMORS“. In X Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов — 2023. Novosibirsk State University, 2023. http://dx.doi.org/10.25205/978-5-4437-1526-1-112.
Der volle Inhalt der QuelleČolović, Mirjana B., Lela B. Korićanac, Jelena J. Žakula, Nada Savić, Tatjana Parac-Vogt und Danijela Z. Krstić. „The influence of Fe(III) incorporation on anti-cancer potential of a Wells- Dawson nanocluster“. In 2nd International Conference on Chemo and Bioinformatics. Institute for Information Technologies, University of Kragujevac, 2023. http://dx.doi.org/10.46793/iccbi23.419c.
Der volle Inhalt der QuelleDezvareh, Homa. „Abstract 5319: Apoptotic properties of platinum antitumor agents phosphaplatins“. In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-5319.
Der volle Inhalt der QuelleCibotaru, Sandu, Andreea-Isabela Sandu, Dalila Belei und Luminita Marin. „Water Soluble PEGylated phenothiazines. Synthesis, Characterization and Antitumor Properties“. In The First International Conference on “Green” Polymer Materials 2020. Basel, Switzerland: MDPI, 2020. http://dx.doi.org/10.3390/cgpm2020-07215.
Der volle Inhalt der QuelleAntosyuk, O. N., und E. V. Bolotnik. „CHANGES VIABILITY INDICATORS OF DROSOPHILA MELANOGASTER WHEN USING EXTRACTS REPRESENTATIVES OF THE GENUS MONARDA REGARDING INFLUENCE ANTI-TUMOR DRUGS“. In I International Congress “The Latest Achievements of Medicine, Healthcare, and Health-Saving Technologies”. Kemerovo State University, 2023. http://dx.doi.org/10.21603/-i-ic-7.
Der volle Inhalt der QuelleOrel, V. E., O. Y. Rykhalskyi, A. Melnyk, A. Shevchuk, A. V. Romanov, A. D. Shevchenko, A. P. Burlaka und S. M. Lukin. „Device for synthesis of antitumor nanocomplex with fixed magnetic properties“. In 2017 IEEE 37th International Conference on Electronics and Nanotechnology (ELNANO). IEEE, 2017. http://dx.doi.org/10.1109/elnano.2017.7939813.
Der volle Inhalt der Quelle